Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.98 Down 0.02(1.99%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,700  1,434  1,277  1,214  
Selling General and Administrative1,050  1,077  1,141  968  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,749) (2,512) (2,418) (2,182)
Income from Continuing Operations
Total Other Income/Expenses Net(413)2,629  (1,376)2,032  
Earnings Before Interest And Taxes(3,162)117  (3,793)(150)
Interest Expense -   -   -   -  
Income Before Tax(3,162)117  (3,793)(150)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,162)117  (3,793)(150)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,162) 117   (3,793) (150)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,162) 117   (3,793) (150)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.